Commercial The Rare Journey Needs a Special Pharmacy Partner Drug ChannelsToday's guest post is from Bansi Nagji, Chief Executive Officer at PANTHERx Rare.CommercialRare DiseaseRead full story pharminent March 27, 2026 (Last updated: March 30, 2026) Drug Channels Today’s guest post is from Bansi Nagji, Chief Executive Officer at PANTHERx Rare. CommercialRare DiseaseRead full story Post navigation Previous: Merck’s deal for Terns sparks debate over a possible biotech bidding warNext: Novartis targets Xolair successor in buyout of startup Excellergy Related Stories Commercial Lilly’s $23B Q2 soars over expectations but Foundayo lags Novo’s rival oral GLP-1 pharminent August 5, 2026 Commercial Leqembi sales grow again after subcutaneous approvals pharminent July 29, 2026 Commercial Wegovy pill launches in UK as first daily oral GLP1 for weight management pharminent July 6, 2026